Whether you’re a senior in high school or a senior-living resident, you’ve likely heard of Viagra (sildenafil) — the original ...

Like other prescription medicines, Viagra and its generic form, sildenafil, work best when you take them under the right ...

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

If you’re on the fence about investing in Patterson Companies, Inc., Hims & Hers Health or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before ...

Financial giants have made a conspicuous bearish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health HIMS revealed 9 unusual trades. Delving into the details ...

Craig Hettenbach, an analyst from Morgan Stanley, maintained the Buy rating on Hims & Hers Health (HIMS – Research Report). The associated price target remains the same with $42.00. Discover the ...

Hims provides digital management tools for appointments, prescriptions, and generic medications for common ED treatments, like sildenafil (Viagra) and tadalafil (Cialis). Hims has also created a ...

Hims & Hers Health Inc (NYSE:HIMS) stock is sitting out the broad market rally today, last seen down 8.4% to trade at $26.15. The personalized healthcare company -- a key player in the weight loss ...

Hims & Hers Health (NYSE:HIMS) is down 7% in early morning trading after the U.S. FDA determined that there is no shortage of Eli Lilly's (LLY) GLP-1 medication tirzepatide, the active ingredient ...

Investing.com -- Shares of Hims & Hers Health, Inc. (NYSE: HIMS) fell sharply by 15% after the U.S. Food and Drug Administration (FDA) announced the resolution of the tirzepatide injection shortage.

Hims & Hers Health (NYSE:HIMS) is rewriting the telehealth playbook while its competitors scramble. With a 200% YTD surge, the company's diversified approachcombining virtual consultations, over ...